Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04852224 · ClinicalTrials.gov registry record
Strength, Aging, and Memory in Prostate Cancer
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 20
- Enrollment target
NCT04852224: Completed study, sponsored by University of Nebraska.
NCT04852224 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04852224 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The objective of this study is to compare changes in neurocognitive function across a 12-month period between three groups: (1) men treated with androgen deprivation therapy (ADT) for prostate cancer (PCa); (2) men under active surveillance for PCa; and (3) men without a history of cancer.
Primary Outcome
Change in interference score on Stroop task, with negative values indicating lower inhibitory control. The Stroop task interference score is a continuous variable with no minimum or maximum value.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2023-04-26 |
What the finished NCT04852224 record still lists
NCT04852224 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04852224 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04852224 about?
NCT04852224 is a clinical study titled "Strength, Aging, and Memory in Prostate Cancer". The objective of this study is to compare changes in neurocognitive function across a 12-month period between three groups: (1) men treated with androgen deprivation therapy (ADT) for prostate cancer (PCa); (2) men under active surveillance for PCa; and (3) men without a history of cancer.
What is the current status of trial NCT04852224?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2021-10-01. Estimated completion is 2023-04-26.
Who is sponsoring clinical trial NCT04852224?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI